Irregular vascular network identified with OCT-A in angioid streaks: A probable predictor of active choroidal neovascularization (case series).


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 20 12 2020
medline: 21 1 2022
entrez: 19 12 2020
Statut: ppublish

Résumé

To evaluate the risk of active choroidal neovascularization (CNV) in presence of deep irregular vascular network (IVN) in eyes with angioid streaks (AS). Observational case series including three treatment-naive eyes with angioid streaks and IVN, without CNV. Patients were followed-up during 18 months with multimodal imaging including structural optical coherence tomography (OCT) and OCT Angiography (OCT-A) to detect possible neovascular complication. On OCT-A, IVN was detected as a peripapillary and/or macular high-flow lesion, filling the spaces between the angioid streaks in the outer retina slab. Repeated OCT-A could detect an active CNV emerging from the IVN, as a high-flow rich anastomotic vascular network with a perilesional dark halo. Patient was treated with intravitreal injections of Bevacizumab on a Pro Re Nata regimen, with a decreased CNV area and lower vascular density on control OCT-A. OCT-A shown to be helpful in detecting the presence of IVN in asymptomatic eyes with AS during a routine examination. In our series, the IVN seems to be predictor of active CNV, needing a close surveillance and frequent follow-up to allow early treatment upon CNV activation.

Identifiants

pubmed: 33339473
doi: 10.1177/1120672120974292
doi:

Substances chimiques

Angiogenesis Inhibitors 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-480

Auteurs

Khaled El Matri (K)

Department B, Institut Hédi Rais d'ophtalmologie de Tunis, Tunis, Tunisia.
Oculogenetic Laboratory LR14SP01, Tunis, Tunisia.
Faculté de médecine de Tunis, Université de Tunis - El Manar, Tunis, Tunisia.

Yousra Falfoul (Y)

Department B, Institut Hédi Rais d'ophtalmologie de Tunis, Tunis, Tunisia.
Oculogenetic Laboratory LR14SP01, Tunis, Tunisia.
Faculté de médecine de Tunis, Université de Tunis - El Manar, Tunis, Tunisia.

Ahmed Chebil (A)

Department B, Institut Hédi Rais d'ophtalmologie de Tunis, Tunis, Tunisia.
Oculogenetic Laboratory LR14SP01, Tunis, Tunisia.
Faculté de médecine de Tunis, Université de Tunis - El Manar, Tunis, Tunisia.

Francesca Amoroso (F)

Ophthalmology Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Faculté de médecine de Créteil, Université Paris Est-Créteil, Créteil, France.

Rim Bouraoui (R)

Department B, Institut Hédi Rais d'ophtalmologie de Tunis, Tunis, Tunisia.
Oculogenetic Laboratory LR14SP01, Tunis, Tunisia.
Faculté de médecine de Tunis, Université de Tunis - El Manar, Tunis, Tunisia.

Leila El Matri (L)

Department B, Institut Hédi Rais d'ophtalmologie de Tunis, Tunis, Tunisia.
Oculogenetic Laboratory LR14SP01, Tunis, Tunisia.
Faculté de médecine de Tunis, Université de Tunis - El Manar, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH